Cardiovascular Considerations Before Cancer Therapy
Zahra Raisi‐Estabragh(Queen Mary University of London), Charlotte Manisty(National Institutes of Health), Kerry L. Reynolds(Massachusetts General Hospital), Peter Libby(Harvard University), Marielle Scherrer‐Crosbie(Massachusetts General Hospital), A. Murphy(Australian Centre for Heart Health), Amy E. Lin(University of California, San Francisco), Sivatharshini Ramalingam(Royal Brompton & Harefield NHS Foundation Trust), Marianne Aznar, Ashu Wechalekar(University College London Hospitals NHS Foundation Trust), Raúl Córdoba(Hospital Universitario Fundación Jiménez Díaz), Christine Bredsen-Masley(St. Michael's Hospital), Teresa López‐Fernández(Hospital Universitario La Paz), Jane Apperley(Hammersmith Hospital), Richard K. Cheng(University of Washington Medical Center)
Cited by 53
Related Papers
Inflammation in Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2012|3.7k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k